May 26, 2021 / 11:00AM GMT
Michael Chu -
Good morning, and thank you for coming to the 2021 Virtual UBS Global Healthcare Conference. My name is Michael, and I'm happy to be your host for this session. Our next presenter will be Chen Schor from Adicet Bio. The Q&A session will follow immediately after the presentation. (Operator Instructions)
I'll now turn it over to Chen. Thank you.
Chen Schor - Adicet Bio, Inc. - CEO, President & Director
Perfect. Good morning, everybody, and thank you for your interest in Adicet. Michael, thank you for inviting us to present at the UBS conference. So at Adicet, we're leading the development of off-the-shelf gamma delta T cells that we engineer to fight cancer. Gamma delta T cells is a therapy that is expected to be an attractive option for patients when we compare it to other allogeneic types of cell therapy such as alpha beta T cells or NK cells or B-specifics. And it's my goal for you guys to understand a little bit the differentiation during this presentation, and I'm happy to address any additional questions in the Q&A.
We
Adicet Bio Inc at UBS Global Healthcare Virtual Conference Transcript
Feb 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers